Ultralife Corporation
ULBI
$11.25
-$0.40-3.43%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.89M | 2.87M | 1.33M | 3.34M | -346.00K |
| Total Depreciation and Amortization | 968.00K | 966.00K | 987.00K | 987.00K | 971.00K |
| Total Amortization of Deferred Charges | 16.00K | 16.00K | 16.00K | 16.00K | 16.00K |
| Total Other Non-Cash Items | 824.00K | 137.00K | 461.00K | 1.44M | -240.00K |
| Change in Net Operating Assets | -4.78M | -1.56M | -3.68M | -4.03M | -1.77M |
| Cash from Operations | -81.00K | 2.43M | -889.00K | 1.75M | -1.37M |
| Capital Expenditure | -372.00K | -1.01M | -534.00K | -516.00K | -497.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -372.00K | -1.01M | -534.00K | -516.00K | -497.00K |
| Total Debt Issued | -- | 1.00M | 1.95M | 2.00M | 2.30M |
| Total Debt Repaid | -500.00K | -1.50M | -500.00K | -500.00K | -500.00K |
| Issuance of Common Stock | 685.00K | 207.00K | 979.00K | 62.00K | -- |
| Repurchase of Common Stock | -- | -8.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 185.00K | -301.00K | 2.43M | 1.56M | 1.80M |
| Foreign Exchange rate Adjustments | 89.00K | -149.00K | 12.00K | -119.00K | -46.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -179.00K | 977.00K | 1.02M | 2.68M | -108.00K |
